Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus Infection

Author： Atay AE   Seven G   Yalcin K   Pasa S   Degertekin H  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.5, 2012-09, pp. : 1891-1896

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine is effective in paediatric patients with chronic hepatitis B virus (HBV) infection

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Clevudine for the treatment of chronic hepatitis B virus infection

By Hui Chee-Kin   Lau George KK  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1277-1284

Informa Healthcare

Access to resources Recommend Favorite

Antineoplastics: Fatal reactivation of hepatitis B virus infection in a HBsAg-negative and anti-HBc-positive patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B

By Spackman D. Eldon   Veenstra David L.  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 937-949

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B

By Veenstra David L.  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 963-977

Adis International

Access to resources Recommend Favorite